TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A Being Patient report explains that observational studies can identify associations between health factors and Alzheimer’s or dementia risk, but cannot establish that one factor causes another. The report cites interventions suggested by observational findings that did not show the expected benefit in clinical trials, while researchers say observational research remains useful where long-term trials are impractical.
Being Patient has published an explainer on what observational studies can—and cannot—show about Alzheimer’s disease, warning that links between habits, medications and dementia risk do not establish that one causes the other. The report says such research can help identify questions for further study, but findings may not hold up when tested in clinical trials.
Observational studies use information from sources such as medical records to examine patterns across groups of people. They can involve very large populations and help researchers identify associations—for example, between a medication or behavior and a later diagnosis. But participants are not randomly assigned to an exposure, so other differences between groups may help explain the result. Association is not proof of causation.
The report describes several examples in which interventions prompted by earlier findings did not produce the anticipated Alzheimer’s benefit in trials. It says semaglutide, a GLP-1 drug used for diabetes and weight loss, did not improve Alzheimer’s symptoms in two large trials; two studies of the antiviral valacyclovir did not treat mild cognitive impairment or early Alzheimer’s symptoms; and a high-dose omega-3 supplement reached the brain but did not provide protection against Alzheimer’s. It also cites a study of exercise and intensive blood-pressure reduction that did not slow decline in healthy older adults over two years.
Brown University assistant professor Sarah Ackley told Being Patient that observational findings can be distorted by unmeasured factors. People may stop drinking coffee because of a health condition that itself affects dementia risk, for instance. Ackley also cautioned against overinterpreting fine-grained comparisons, such as different reported effects for leisure-time and work-related exercise. Underlying health and social differences may help explain such patterns.
Why Risk Associations Need Testing
The distinction matters because headlines about a food, drug or routine can sound like direct instructions, even when the underlying study only identifies a correlation. Treating an association as a proven preventive measure can lead people to worry unnecessarily or make decisions on evidence that has not established cause and effect. Ackley told Being Patient she worries that people may overinterpret the evidence and feel stressed.
At the same time, observational research can guide scientists toward possible risk factors and treatments, especially when a randomized trial would be impractical, too costly or require decades of follow-up. Ackley gave the example of studying hypertension’s relationship to dementia: researchers cannot readily run a 30-year trial assigning people to have high blood pressure. The research may also reveal population-level patterns even when an effect on any one person is small. Its value is in generating and refining questions, not in serving as a stand-alone prescription.
Products Worth Considering
Oral-B iO Series 3 Rechargeable Electric Toothbrush for Adults, Black, 3 Modes, 2 Brush Heads and Travel Case
Fitbit Inspire 3 Health and Fitness Tracker Bundle
Fitbit Versa 2 Health and Fitness Smartwatch with Heart Rate, Alexa, Music, Sleep and Swim Tracking
As an affiliate, we earn on qualifying purchases.
From Population Patterns to Trials
Alzheimer’s develops over a long period, according to the report, with disease-linked proteins building up before symptoms appear. That timeline can make short studies a poor test of whether an intervention changes the disease’s course. The report notes that some observational studies of GLP-1 drugs suggested protective effects within as little as 90 days, a timescale Ackley said sits uneasily with evidence that Alzheimer’s develops over decades.
“If this drug works, it should work over years, not over months,” Ackley told Being Patient. She said any benefit from these drugs might emerge gradually through effects on blood glucose and cardiovascular risk. The report says the observational evidence was strong enough for Novo Nordisk to move semaglutide directly to a Phase 3 study, but that research step does not itself establish that the drug prevents or treats Alzheimer’s.
The report also cautions against treating small lifestyle associations as decisive. Ackley said people need not organize their lives around eating more blueberries to prevent dementia. It presents healthy eating, exercise and management of cardiovascular risk factors as broadly relevant to brain health, while stressing that observational studies alone cannot quantify a guaranteed benefit for an individual.
““I worry about people over interpreting the evidence and stressing out.””
— Sarah Ackley, assistant professor at Brown University, speaking to Being Patient
What the Studies Cannot Establish
The supplied report does not provide full citations, sample sizes or detailed results for each study it mentions, so those details cannot be independently assessed from this material. It also does not state the publication date of the explainer. The examples are described in summary, and the report does not establish that every observational finding fails in a trial.
For any individual association, it may be unclear whether the factor itself contributes to risk, whether another condition or social circumstance explains the pattern, or whether the finding reflects chance. The report does not establish that semaglutide or other interventions prevent Alzheimer’s. It also does not quantify the long-term effect of general lifestyle measures on an individual’s dementia risk. Those questions require further evidence, including appropriately designed trials and longer follow-up where feasible.
Testing Signals Over Longer Periods
The next step for a promising observational signal is further research that can better test whether the relationship is causal. Depending on the question, that may include randomized clinical trials, longer follow-up, or studies designed to account for differences in health and circumstances between participants. The report says Novo Nordisk advanced semaglutide to a Phase 3 study, but gives no trial results or timetable in the material provided.
Readers should treat claims that a particular food, medication or exercise pattern prevents Alzheimer’s as unproven unless supported by suitable evidence. The report’s broader takeaway is that observational studies help identify leads, while clinical trials and additional research determine whether those leads translate into reliable effects.
Key Questions
What is an observational study?
It is research that examines patterns in people’s health information or behavior without randomly assigning participants to receive a treatment or follow a behavior. It can identify associations, but by itself cannot establish cause and effect.
Does a link between a habit and dementia risk mean the habit causes the difference?
No. Other factors—including health conditions or differences between groups—may account for some or all of the association. Further research is needed to test whether the factor itself affects risk.
Did the trials discussed in the report show that semaglutide prevents Alzheimer’s?
No. The report says two large trials found semaglutide did not treat Alzheimer’s symptoms. It also says observational findings led Novo Nordisk to pursue a Phase 3 study; that decision is not evidence that the drug prevents Alzheimer’s.
Why conduct observational studies if they cannot prove causation?
They can examine large populations and identify possible leads, including questions that are difficult to study in long randomized trials. Researchers can then use other study designs to test those leads.
Does the report recommend a specific food or exercise routine to prevent Alzheimer’s?
No specific routine is established by the report. It describes healthy eating, exercise and management of cardiovascular risk factors as relevant to long-term brain health, while cautioning that observational findings do not guarantee an individual benefit. For personal health decisions, consult a qualified health professional.
Source: beingpatient.com
